a2 Milk made strong gains in Chinese infant formula market share in the first half on excellent marketing and execution, Credit Suisse declares. Brand awareness continues to improve in China. Upside risk is nonetheless difficult because the Chinese infant formula demand rate of decline appears to have quickened. The broker's modelling now suggests a further -10% decline in demand in 2023. Credit Suisse is concerned the China re-registration process could cause market disorder. Downgrade to Underperform from Neutral on valuation. Target falls to $5.10 from $5.30.
a2 Milk made strong gains in Chinese infant formula market share...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.03 |
Change
0.130(1.88%) |
Mkt cap ! $5.082B | |||
| Open | High | Low | Value | Volume |
| $6.91 | $7.06 | $6.88 | $23.49M | 3.356M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10650 | $7.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.04 | 7256 | 2 |
View Market Depth
| Last trade - 16.10pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.02 |
Change
0.130 ( 1.73 %) |
||||
| Open | High | Low | Volume | ||
| $6.91 | $7.06 | $6.87 | 933444 | ||
| Last updated 15.59pm 23/05/2024 ? | |||||
| A2M (ASX) Chart |